688626.SH
翔宇医疗
SSE · Healthcare · Medical - Specialties · CN
CNY 41.69
−4.60%Year over year
Reported trailing growth
- Revenue
- +1.9%
- EBITDA
- —
- EBIT
- -16.0%
- EPS
- -6.8%
- Free cash flow
- +78.6%
- Operating cash flow
- +5.9%
Forward estimates
Based on analyst estimates
- Revenue
- -78.8%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +16.3%
- EBITDA
- -3.5%
- EBIT
- -17.3%
- Net income
- -14.6%
- EPS
- -13.6%
- Free cash flow
- +62.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026